Stock Scorecard
Stock Summary for Dexcom Inc (DXCM) - $62.39 as of 11/28/2025 3:33:28 PM EST
Total Score
13 out of 30
Safety Score
53 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for DXCM
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for DXCM
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for DXCM
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for DXCM
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for DXCM (53 out of 100)
| Stock Price Rating (Max of 10) | 9 |
| Historical Stock Price Rating (Max of 10) | 10 |
| Stock Price Trend (Max of 10) | 1 |
| Book Value (Max of 10) | 4 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 4 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 5 |
| Trading Volume (Max of 10) | 10 |
| Price to Earnings (Max of 10) | 5 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for DXCM
Financial Details for DXCM
Company Overview |
|
|---|---|
| Ticker | DXCM |
| Company Name | Dexcom Inc |
| Country | USA |
| Description | DexCom, Inc. is a prominent leader in diabetes care, renowned for its groundbreaking continuous glucose monitoring (CGM) systems that empower patients to manage their diabetes effectively. Headquartered in San Diego, California, with a strategic manufacturing facility in Mesa, Arizona, the company is dedicated to advancing diabetes management through innovative technology and exceptional product quality. As a pioneer in glucose monitoring, DexCom is actively expanding its global presence to meet the rising demand for effective diabetes solutions, positioning itself as a key player in the evolving healthcare landscape. |
| Sector Name | HEALTHCARE |
| Industry Name | MEDICAL DEVICES |
| Most Recent Quarter | 9/30/2025 |
| Next Earnings Date | N/A |
Stock Price History |
|
| Last Day Price | 62.39 |
| Price 4 Years Ago | 134.24 |
| Last Day Price Updated | 11/28/2025 3:33:28 PM EST |
| Last Day Volume | 2,254,716 |
| Average Daily Volume | 7,294,903 |
| 52-Week High | 93.25 |
| 52-Week Low | 54.11 |
| Last Price to 52 Week Low | 15.30% |
Valuation Measures |
|
| Trailing PE | 34.74 |
| Industry PE | 45.47 |
| Sector PE | 89.93 |
| 5-Year Average PE | 91.86 |
| Free Cash Flow Ratio | 13.25 |
| Industry Free Cash Flow Ratio | 27.76 |
| Sector Free Cash Flow Ratio | 29.09 |
| Current Ratio Most Recent Quarter | 1.56 |
| Total Cash Per Share | 4.71 |
| Book Value Per Share Most Recent Quarter | 6.99 |
| Price to Book Ratio | 8.95 |
| Industry Price to Book Ratio | 4.37 |
| Sector Price to Book Ratio | 33.13 |
| Price to Sales Ratio Twelve Trailing Months | 5.43 |
| Industry Price to Sales Ratio Twelve Trailing Months | 5.94 |
| Sector Price to Sales Ratio Twelve Trailing Months | 16.04 |
| Analyst Buy Ratings | 20 |
| Analyst Strong Buy Ratings | 4 |
Share Statistics |
|
| Total Shares Outstanding | 390,016,000 |
| Market Capitalization | 24,333,098,240 |
| Institutional Ownership | 99.55% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.41% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 109.90% |
| Annual Earnings Growth | 6.41% |
| Reported EPS 12 Trailing Months | 1.80 |
| Reported EPS Past Year | 1.41 |
| Reported EPS Prior Year | 1.58 |
| Net Income Twelve Trailing Months | 720,700,000 |
| Net Income Past Year | 576,200,000 |
| Net Income Prior Year | 541,500,000 |
| Quarterly Revenue Growth YOY | 21.60% |
| 5-Year Revenue Growth | 22.27% |
| Operating Margin Twelve Trailing Months | 20.10% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 1,835,700,000 |
| Total Cash Past Year | 606,100,000 |
| Total Cash Prior Year | 566,300,000 |
| Net Cash Position Most Recent Quarter | 595,800,000 |
| Net Cash Position Past Year | -630,900,000 |
| Long Term Debt Past Year | 1,237,000,000 |
| Long Term Debt Prior Year | 2,434,200,000 |
| Total Debt Most Recent Quarter | 1,239,900,000 |
| Equity to Debt Ratio Past Year | 0.63 |
| Equity to Debt Ratio Most Recent Quarter | 0.69 |
| Total Stockholder Equity Past Year | 2,102,600,000 |
| Total Stockholder Equity Prior Year | 2,068,600,000 |
| Total Stockholder Equity Most Recent Quarter | 2,726,100,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 1,061,900,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 2.72 |
| Free Cash Flow Past Year | 630,700,000 |
| Free Cash Flow Prior Year | 511,900,000 |
Options |
|
| Put/Call Ratio | 0.36 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -1.51 |
| MACD Signal | -2.21 |
| 20-Day Bollinger Lower Band | 51.94 |
| 20-Day Bollinger Middle Band | 71.20 |
| 20-Day Bollinger Upper Band | 90.46 |
| Beta | 1.52 |
| RSI | 48.63 |
| 50-Day SMA | 77.20 |
| 150-Day SMA | 97.41 |
| 200-Day SMA | 97.57 |
System |
|
| Modified | 11/28/2025 9:21:09 PM EST |